CoChat

Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial

Open access

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

Antidepressant doses of ketamine rapidly facilitate synaptic plasticity and modify neuronal function within prefrontal and hippocampal circuits. However, most studies have demonstrated these effects in animal models and translational studies in humans are scarce. A recent animal study showed that ketamine restored dendritic spines in the hippocampal CA1 region within 1 h of administration. To translate these results to humans, this randomized, double-blind, placebo-controlled, crossover magnetic resonance imaging (MRI) study assessed ketamine’s rapid neuroplastic effects on hippocampal subfield measurements in healthy volunteers. S-Ketamine vs. placebo data were analyzed, and data were also grouped by brain-derived neurotrophic factor (BDNF) genotype. Linear mixed models showed that overall hippocampal subfield volumes were significantly larger (p = 0.009) post ketamine than post placebo (LS means difference=0.008, standard error=0.003). Post-hoc tests did not attribute effects to specific subfields (all p > 0.05). Trend-wise volumetric increases were observed within the left hippocampal CA1 region (p = 0.076), and trend-wise volumetric reductions were obtained in the right hippocampal—amygdaloid transition region (HATA) (p = 0.067). Neither genotype nor a genotype–drug interaction significantly affected the results (all p > 0.7). The study provides evidence that ketamine has short-term effects on hippocampal subfield volumes in humans. The results translate previous findings from animal models of depression showing that ketamine has pro-neuroplastic effects on hippocampal structures and underscore the importance of the hippocampus as a key region in ketamine’s mechanism of action.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-021-01318-6

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Study design. Thirty-one healthy subjects (mean age: 25.2 years) underwent two magnetic resonance imaging (MRI) scans—one with ketamine, the other with placebo (saline)—in a randomized order at least 1 week apart. Each subject received a bolus of 0.11 mg/kg S-ketamine hydrochloride followed by a maintenance infusion of 0.12 mg/kg over 20 min. Structural MRI (sMRI) sequences were obtained at baseline and 65 min after the start of the infusion. As part of an earlier study, each subject underwent functional MRI (fMRI) before and after sMRI.
Fig. 1 Study design. Thirty-one healthy subjects (mean age: 25.2 years) underwent two magnetic resonance imaging (MRI) scans—one with ketamine, the other with placebo (saline)—in a randomized order at least 1 week apart. Each subject received a bolus of 0.11 mg/kg S-ketamine hydrochloride followed by a maintenance infusion of 0.12 mg/kg over 20 min. Structural MRI (sMRI) sequences were obtained at baseline and 65 min after the start of the infusion. As part of an earlier study, each subject underwent functional MRI (fMRI) before and after sMRI.CC BY · PubMed Central
Fig. 2 Mixed model estimates of ketamine versus placebo in hippocampal subfields. Linear mixed effects modelling of estimates of volumetric differences 65 min post-ketamine and post-placebo administration. Trend-wise differences between ketamine and placebo were observed in the left CA1 (p = 0.076) and the right HATA (p = 0.067). Bars represent estimated means and 95% confidence intervals adjusted for sex, age, and total hippocampal volume. Values correspond to those in Table 1. CA1, CA2, CA3, of the ammon’s horn; GC-ML-DG, granule cells, molecular layer, dentate gyrus; HATA, hippocampal-amygdaloid transition area; mol_HP, molecular layer hippocampus.
Fig. 2 Mixed model estimates of ketamine versus placebo in hippocampal subfields. Linear mixed effects modelling of estimates of volumetric differences 65 min post-ketamine and post-placebo administration. Trend-wise differences between ketamine and placebo were observed in the left CA1 (p = 0.076) and the right HATA (p = 0.067). Bars represent estimated means and 95% confidence intervals adjusted for sex, age, and total hippocampal volume. Values correspond to those in Table 1. CA1, CA2, CA3, of the ammon’s horn; GC-ML-DG, granule cells, molecular layer, dentate gyrus; HATA, hippocampal-amygdaloid transition area; mol_HP, molecular layer hippocampus.CC BY · PubMed Central
Fig. 3 Absolute volumes of the left and right hippocampi before and after ketamine and placebo administration. A paired t-test comparison of absolute volumetric differences before and after ketamine or placebo found that neither ketamine nor placebo had any effect on the total hippocampal volume (all p > 0.05).
Fig. 3 Absolute volumes of the left and right hippocampi before and after ketamine and placebo administration. A paired t-test comparison of absolute volumetric differences before and after ketamine or placebo found that neither ketamine nor placebo had any effect on the total hippocampal volume (all p > 0.05).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Cited by

See all 38

Metadata

Authors
Höflich, A., Kraus, C., Pfeiffer, R. M., Seiger, R., Rujescu, D., Zarate, C. A., Kasper, S., Winkler, D., & Lanzenberger, R.
Affiliations
  • Medical University of Vienna (AT)
  • National Institutes of Health (US)
  • Martin Luther University Halle-Wittenberg (DE)
Corresponding author
Lanzenberger, Rupert
Venue
Translational Psychiatry
Published
2021-04-01
Volume
11
Issue
1
Pages
200-200
ISSN
2158-3188 (ISSN-L)
OpenAlex
W3146692759
Cited by
34
References
60
Citations by year
2026: 3 · 2025: 7 · 2024: 10 · 2023: 7 · 2022: 5 · 2021: 2
FWCI
3.50
Type
journal article
Language
en
Open access
Licence
Locations
  • Translational Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Intramural Research Program at the National Institute of Mental Health, National Institutes of Health
  • Oesterreichische Nationalbank (P 14193)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords
esketamine, hippocampal subfields, hippocampal volume, CA1 region, rapid-acting antidepressants, synaptic plasticity, neuroplasticity, dendritic spines, healthy volunteers
MeSH terms
Antidepressive Agents, Double-Blind Method, Hippocampus, Humans, Ketamine, Magnetic Resonance Imaging, Cross-Over Studies, Healthy Volunteers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial. https://app.cochat.ai/papers/10.1038/s41398-021-01318-6
The paper
Höflich, A., Kraus, C., Pfeiffer, R. M., Seiger, R., Rujescu, D., Zarate, C. A., Kasper, S., Winkler, D., & Lanzenberger, R. (2021). Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial. Translational Psychiatry. https://doi.org/10.1038/s41398-021-01318-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.